P. Auzeloux

发表

Small rigid platforms functionalization with quaternary ammonium: targeting extracellular matrix of chondrosarcoma.

O. Tillement, David Kryza, P. Bonazza, 2014, Nanomedicine : nanotechnology, biology, and medicine.

Internal dosimetry through GATE simulations of preclinical radiotherapy using a melanin-targeting ligand

N. Moins, J. Papon, J. Chezal, 2014, Physics in medicine and biology.

First ex vivo study demonstrating that 99mTc-NTP 15-5 radiotracer binds to human articular cartilage

J. Madelmont, J. Chezal, E. Miot-Noirault, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma.

J. Maublant, C. Lartigue, N. Moins, 2008, Bioorganic & medicinal chemistry.

Synthesis, radioiodination and in vivo screening of novel potent iodinated and fluorinated radiotracers as melanoma imaging and therapeutic probes.

N. Moins, J. Papon, J. Madelmont, 2013, European journal of medicinal chemistry.

Simultaneous proteoglycans and hypoxia mapping of chondrosarcoma environment by frequency selective CEST MRI

J. Bonny, E. Miot-Noirault, G. Pagés, 2021, Magnetic resonance in medicine.

Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [18F]ICF01006, a highly promising melanoma PET tracer

N. Moins, J. Chezal, E. Miot-Noirault, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy

M. D’Incan, S. Besse, A. Hennino, 2020, Cancer Immunology, Immunotherapy.

Benzamide derivative radiotracers targeting melanin for melanoma imaging and therapy: Preclinical/clinical development and combination with other treatments.

F. Cachin, P. Auzeloux, F. Degoul, 2021, Pharmacology & therapeutics.

Radiation dosimetry of [131I]ICF01012 in rabbits: Application to targeted radionuclide therapy for human melanoma treatment

J. Chezal, E. Miot-Noirault, L. Maigne, 2018, Medical physics.

99mTc-NTP 15-5 is a companion radiotracer for assessing joint functional response to sprifermin (rhFGF-18) in a murine osteoarthritis model

F. Berenbaum, E. Miot-Noirault, Arnaud Briat, 2022, Scientific Reports.

Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol

X. Durando, J. Chezal, E. Miot-Noirault, 2022, BMC cancer.

In vivo scintigraphic imaging of proteoglycans.

J. Madelmont, J. Chezal, E. Miot-Noirault, 2012, Methods in molecular biology.

Assessment of 99mTc-NTP 15-5 uptake on cartilage, a new proteoglycan tracer: Study protocol for a phase I trial (CARSPECT)

F. Penault-Llorca, X. Durando, E. Miot-Noirault, 2022, Frontiers in Medicine.

A“Proteoglycan Targeting Strategy” for the Scintigraphic Imaging and Monitoring of the Swarm Rat Chondrosarcoma Orthotopic Model

J. Chezal, E. Miot-Noirault, D. Heymann, 2011, Sarcoma.

Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms☆

J. Chezal, E. Miot-Noirault, S. Besse, 2019, Translational oncology.

Synthesis of two novel oxocyclam-binding technetium complexes containing an analogue of cocaine

P. Emond, E. Berthommier, P. Auzeloux, 2002 .

In vivo experimental imaging of osteochondral defects and their healing using 99mTc-NTP 15-5 radiotracer

J. Chezal, E. Miot-Noirault, S. Askienazy, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Internal dosimetry of [99m Tc]NTP15-5 radiotracer for cartilage imaging in preclinical and clinical models using the GATE Monte Carlo platform.

E. Miot-Noirault, L. Maigne, C. Valla, 2020, Medical physics.

Synthesis, radiolabeling and preliminary in vivo evaluation of multimodal radiotracers for PET imaging and targeted radionuclide therapy of pigmented melanoma.

J. Madelmont, J. Chezal, E. Miot-Noirault, 2015, European journal of medicinal chemistry.

Synthesis and biodistribution of a new oxo-technetium-99m bis(aminothiol) complex as a potential melanoma tracer.

R. Pasqualini, J. Papon, J. Madelmont, 2001, Journal of medicinal chemistry.

A potential melanoma tracer: synthesis, radiolabeling, and biodistribution in mice of a new nitridotechnetium bis(aminothiol) derivative pharmacomodulated by a N-(diethylaminoethyl)benzamide.

R. Pasqualini, J. Papon, J. Madelmont, 2000, Journal of medicinal chemistry.

Macrocyclic 14-Membered Ring Diketal Diamines: Synthesis, Conformational Analysis and 99mTc Radiolabeling Evaluation

J. Madelmont, P. Auzeloux, D. Dugat, 2008 .

Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies

J. Chezal, E. Miot-Noirault, D. Heymann, 2012, Investigational New Drugs.

Synthesis, radiofluorination, and in vivo evaluation of novel fluorinated and iodinated radiotracers for PET imaging and targeted radionuclide therapy of melanoma.

N. Moins, J. Madelmont, J. Chezal, 2013, Journal of medicinal chemistry.

Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma

L. Larue, V. Petit, T. Billoux, 2021, Cancers.

Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy1

N. Moins, F. Mishellany, J. Chezal, 2016, Neoplasia.

Technetium‐99m radiolabelling of an N‐amino‐alkyl‐benzamide nitrido‐ and oxo‐technetium bis(aminoethanethiol) derivative synthesis and biological results. Potential melanoma tracer agents

R. Pasqualini, J. Papon, M. Moreau, 1999 .

Synthesis and biodistribution of technetium-99m-labelled N-(diethylaminoethyl)benzamide via a bis(dithiocarbamate) nitridotechnetium(V) complex

A. Veyre, R. Pasqualini, J. Papon, 1999 .

Single photon emission computed tomography/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracers.

R. Boisgard, B. Tavitian, N. Moins, 2011, Journal of medicinal chemistry.

Single Photon Emission Computed Tomography / Positron Emission Tomography Imaging and Targeted Radionuclide Therapy ofMelanoma : NewMultimodal Fluorinated and IodinatedRadiotracers

B. Tavitian, N. Moins, J. Papon, 2011 .

Synthesis of all-trans-beta-carotene retinoids and derivatives labelled with 14C

A. Veyre, J. Madelmont, P. Grolier, 1996 .

Proteoglycans as Target for an Innovative Therapeutic Approach in Chondrosarcoma: Preclinical Proof of Concept

J. Chezal, E. Miot-Noirault, M. Dauplat, 2016, Molecular Cancer Therapeutics.

First in Vivo SPECT Imaging of Mouse Femorotibial Cartilage Using 99mTc-NTP 15-5

J. Maublant, N. Moins, J. Madelmont, 2008, Molecular Imaging.

Development of a freeze-dried kit formulation for the preparation of 99mTc-NTP 15-5, a radiotracer for scintigraphic imaging of proteoglycans.

J. Chezal, E. Miot-Noirault, S. Besse, 2015, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Development and Preliminary Evaluation of TFIB, a New Bimodal Prosthetic Group for Bioactive Molecule Labeling.

J. Chezal, E. Miot-Noirault, E. Débiton, 2015, ACS Medicinal Chemistry Letters.

99mTc-NTP 15-5 Imaging for Cartilage Involvement in Experimental Rheumatoid Arthritis: Comparison with Routinely Used Molecular Imaging Methods and Sensitivity to Chronic Nonsteroidal Antiinflammatory Drug Treatment

M. Etienne, A. Eschalier, D. Ardid, 2015, The Journal of Nuclear Medicine.

Stable tumor vessel normalization with pO2 increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment

G. Collet, C. Kieda, J. Lehn, 2013, Journal of Molecular Medicine.